Apimeds Pharmaceuticals US, Inc Skyrocketed
Tue, May 05, 2026 at 07:54 PM
Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT) rocketted at $3, representing a gain of 59.6%. On Tue, May 05, 2026, APUS:NYSEMKT hit a New 2-Week High of $3. The stock got featured on our News Catalysts scanner on Tue, May 05, 2026 at 03:32 PM in the 'MERGER' category. From Tue, Apr 21, 2026, the stock recorded 10.00% Up Days and 100.00% Green Days
The stock spiked on Tue, May 05, 2026 at $5.97 with a volume of 5M+.
About Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT)
Apimeds Pharmaceuticals US is a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits...
Top 10 Gainers:
- Phoenix Asia Holdings Limited (PHOE:NASDAQ), 168.51%
- Smart for Life, Inc. (SMFL:NASDAQ), 100%
- Sadot Group Inc. (SDOT:NASDAQ), 91.19%
- Backblaze, Inc. (BLZE:NASDAQ), 63.58%
- EverQuote, Inc. (EVER:NASDAQ), 63.04%
- Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT), 59.57%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 54.48%
- SelectQuote, Inc. (SLQT:NYSE), 52.43%
- Sterling Infrastructure, Inc. (STRL:NASDAQ), 52.22%
- 3 E Network Technology Group Limited (MASK:NASDAQ), 44.14%